初步数据显示:ImmunityBio公司Anktiva®联合NK细胞疗法及Optune Gio®设备治疗复发性胶质母细胞瘤,5名患者中实现100%疾病控制,其中2名患者接近完全缓解

美股速递
Aug 26, 2025

初步数据显示:ImmunityBio公司Anktiva®联合NK细胞疗法及Optune Gio®设备治疗复发性胶质母细胞瘤,5名患者中实现100%疾病控制,其中2名患者接近完全缓解

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10